Atlas FDA

INTERSTIM THERAPY SYSTEM (FOR URINARY CONTROL)

FDA premarket approval P970004/S225 · decided 2016-11-10

Approval details

PMA number
P970004
Supplement
S225
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
INTERSTIM THERAPY SYSTEM (FOR URINARY CONTROL)
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2016-08-15
Decision date
2016-11-10
Days to decision
87 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
Approval for updates to patient and physician labeling for Medtronic Sacral Neuromodulation (SNM) Therapy.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23